Our library of clinical trials information is updated regularly from the US government database on clinical trials, so you can be assured that new esomeprazole clinical trials listings will be included here shortly after becoming available to us.
Related Sponsors
Clinical Trials on esomeprazole
- A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (Study CL2008-02)(COMPLETED)
Status: Completed, Condition Summary: Gastric Acid; Human Experimentation - Study Comparing a Fixed-Dose Capsule of Esomeprazole 40mg and LDA 325mg With Free Combination
Status: Completed, Condition Summary: Ulcers; Upper GI Symptoms - A Pharmacokinetic (PK) Study Evaluating Naproxen and Esomeprazole Plasma Levels
Status: Active, not recruiting, Condition Summary: Arthritis - A Pharmacodynamic Study Comparing Zegerid® and Prilosec OTC® (COMPLETED)
Status: Completed, Condition Summary: Gastric Acid; Human Experimentation - Phase 1 Pharmacokinetics of Intravenous Nexium in Children
Status: Recruiting, Condition Summary: Pharmacokinetics - A Study of Nexium (Esomeprazole) 40 mg Once Daily in Subjects With Symptoms of Gastroesophageal Reflux Disease (GORD) After Treatment With a Full Dose of Proton Pump Inhibitor (PPI)
Status: Active, not recruiting, Condition Summary: Gastroesophageal Reflux Disease - Inhibition of Gastric Acid is the Key to Satisfactory Relief of Symptoms With Esomeprazole in NUD Patients
Status: Completed, Condition Summary: Indigestion - Esomeprazole With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus
Status: Recruiting, Condition Summary: Esophageal Cancer; Precancerous/Nonmalignant Condition - The Effect of Nexium and Probiotics on Insulin Secretion and Cardiovascular Risk Factors in Patients With Type 2 Diabetes
Status: Recruiting, Condition Summary: Type 2 Diabetes - Pharmacokinetic Study of Esomeprazole Magnesium in Patients 1 to 11 Years-Old With Endoscopically-Proven Gastroesophageal Reflux Disease (GERD)
Status: Completed, Condition Summary: Endoscopically-Proven GERD; Reflux - Impact of Timing on the Efficacy of Zegerid 40 mg in Healing Reflux Esophagitis: A Pilot Study
Status: Recruiting, Condition Summary: Errosive Esophagitis - Does Omeprazole Decrease Intestinal Calcium Absorption?
Status: Active, not recruiting, Condition Summary: Osteoporosis; Achlorhydria; GERD; Hip Fracture - Comparison of the Gastric Acid Suppressive Effects of Esomeprazole and Generic Omeprazole
Status: Recruiting, Condition Summary: Gastric Acid - Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma
Status: Completed, Condition Summary: Asthma; GERD - Nexium RESPONSE Trial
Status: Active, not recruiting, Condition Summary: GERD - Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed
Status: Completed, Condition Summary: Erosive Esophagitis - A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Erosive Esophagitis
Status: Completed, Condition Summary: Erosive Esophagitis - Study Comparing Esomeprazole Magnesium 40mg Once Daily Versus Lansoprazole 30 mg Twice Daily in Symptom Control of Subjects With Persistent GERD
Status: Completed, Condition Summary: Heartburn; Gastroesophageal Reflux Disease - A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued in Subjects in the US Only
Status: Completed, Condition Summary: NSAID Associated Gastric Ulcers - Reflux Esophagitis Phase III Study (Maintenance Treatment)
Status: Recruiting, Condition Summary: Reflux Esophagitis - Barrett's Esophagus - 315 - 3 Way Cross Over
Status: Completed, Condition Summary: Barrett's Esophagus - A Comparative Efficacy and Safety Study of Nexium Delayed-Release Capsules (40mg qd and 20mg qd) Versus Ranitidine 150mg Bid for the Healing of NSAID-Associated Gastric Ulcers When Daily NSAID Use is Continued
Status: Completed, Condition Summary: NSAID Associated Gastric Ulcers - Barrett's Esophagus - 315 - 3 Way Cross-Over
Status: Completed, Condition Summary: Barrett's Esophagus - Reflux Esophagitis Phase III Study (Initial Treatment)
Status: Recruiting, Condition Summary: Reflux Esophagitis - Comparison of Esomeprazole and Famotidine for Stress Ulcer Prophylaxis in Neurosurgical Intensive Care Unit
Status: Recruiting, Condition Summary: Ulcer - Open, Randomized, Two Way Crossover 40mg, Orally and Intravenously
Status: Completed, Condition Summary: GERD - Prevention of Gastric Ulcers
Status: Completed, Condition Summary: NSAID Associated Gastric Ulcers - Ulcer Prevention II
Status: Completed, Condition Summary: NSAID Associated Gastric Ulcers - A Randomized, Open-Label, Comparative 3-Way Treatment Crossover Study of 24-Hour Intragastric pH Profile of Once Daily Oral Administration of Esomeprazole 40mg, Lansoprazole 30mg, and Pantoprazole 40mg at Steady State in NSAID-Using Patients
Status: Completed, Condition Summary: Heartburn; Upper Abdominal Pain; Nausea; Acid Regurgitation - An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)
Status: Completed, Condition Summary: GERD